Related Experiment Videos

[Hypertrophic cardiomyopathy treated by interventional technique of septal reduction]

J A Marin-Neto1, M O Lima Filho, A Schmidt

  • 1Hospital das Cínicas da Faculdade de Medicina de Ribeirão Preto--USP.

Insights

Percutaneous alcohol septal ablation effectively treated obstructive hypertrophic cardiomyopathy in a patient unsuitable for traditional interventions. This minimally invasive procedure relieved severe dyspnea and eliminated the dangerous left ventricular outflow tract obstruction.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Obstructive hypertrophic cardiomyopathy (oHCM) presents significant challenges, especially in patients with contraindications to standard treatments like pacemakers or surgery.
  • Medical management often fails to adequately control symptoms in advanced cases.

Observation:

  • A 75-year-old woman with severe, refractory dyspnea due to oHCM was considered a high-risk candidate for conventional therapies.
  • A novel percutaneous approach was chosen, involving selective alcohol injection into a septal branch of the left anterior descending artery.

Findings:

  • The procedure induced a controlled septal infarction, evidenced by ECG changes and enzyme elevation.
  • The left ventricular outflow tract pressure gradient decreased from 66mmHg to zero immediately post-intervention.
  • The patient experienced significant symptomatic improvement and sustained gradient reduction at two-month follow-up.

Implications:

  • Percutaneous alcohol septal ablation offers a viable, less invasive therapeutic option for select oHCM patients.
  • This technique can effectively reduce left ventricular outflow tract obstruction and improve quality of life.
  • Further research into this interventional strategy for refractory oHCM is warranted.

Related Concept Videos